Wells Fargo’s Axcella Health Inc. Common Stock AXLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-8
| Closed | -$84 | – | 7843 |
|
|
2023
Q3 | $84 | Sell |
8
-4
| -33% | -$31 | ﹤0.01% | 6813 |
|
|
2023
Q2 | $67 | Sell |
12
-92
| -88% | -$863 | ﹤0.01% | 6977 |
|
|
2023
Q1 | $1.25K | Hold |
104
| – | – | ﹤0.01% | 6319 |
|
|
2022
Q4 | $848 | Buy |
104
+46
| +79% | +$1.19K | ﹤0.01% | 6237 |
|
|
2022
Q3 | $2K | Sell |
58
-2
| -3% | -$106 | ﹤0.01% | 6233 |
|
|
2022
Q2 | $3K | Buy |
60
+16
| +36% | +$787 | ﹤0.01% | 6259 |
|
|
2022
Q1 | $3K | Sell |
44
-12
| -21% | -$599 | ﹤0.01% | 6621 |
|
|
2021
Q4 | $3K | Buy |
56
+12
| +27% | +$842 | ﹤0.01% | 6840 |
|
|
2021
Q3 | $3K | Sell |
44
-1
| -2% | -$86 | ﹤0.01% | 6525 |
|
|
2021
Q2 | $4K | Sell |
45
-189
| -81% | -$18.7K | ﹤0.01% | 6422 |
|
|
2021
Q1 | $28K | Sell |
234
-586
| -71% | -$82.7K | ﹤0.01% | 6060 |
|
|
2020
Q4 | $107K | Buy |
820
+162
| +25% | +$20.8K | ﹤0.01% | 5335 |
|
|
2020
Q3 | $76K | Sell |
658
-44
| -6% | -$5.42K | ﹤0.01% | 5358 |
|
|
2020
Q2 | $98K | Buy |
702
+228
| +48% | +$27.9K | ﹤0.01% | 5233 |
|
|
2020
Q1 | $40K | Buy |
474
+445
| +1,534% | +$45.6K | ﹤0.01% | 5419 |
|
|
2019
Q4 | $2K | Buy |
29
+22
| +314% | +$2.42K | ﹤0.01% | 6203 |
|
|
2019
Q3 | $1K | Buy |
7
+6
| +600% | +$1.11K | ﹤0.01% | 6318 |
|
|
2019
Q2 | $0 | Buy |
+1
| New | +$317 | ﹤0.01% | 6701 |
|
Other funds holding AXLA
Wells Fargo's AXLA Position: Q4 2023 in Review
Wells Fargo sold out of Axcella Health Inc. Common Stock (AXLA) in Q4 2023, closing a stake of 8 shares — an estimated $84 sold.
Wells Fargo first reported a position in AXLA in Q2 2019 and held it in 18 quarters. The position peaked at $107K in Q4 2020. 1 fund tracked by Wall St. Rank holds AXLA as of Q4 2023.
- Wells Fargo reported no remaining Axcella Health Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Wells Fargo sold 8 Axcella Health Inc. Common Stock shares in Q4 2023, an estimated $84.
- Wells Fargo first reported a position in Axcella Health Inc. Common Stock in Q2 2019 and held it in 18 quarters.
- Wells Fargo's Axcella Health Inc. Common Stock position peaked at $107K in Q4 2020.
- 1 fund tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q4 2023.
Based on Wells Fargo's 13F filing for Q4 2023, filed 9 Feb 2024.